Skip to main content
SpringerLink
Log in

Krankheitsrisiko und Nutzen der Therapie bei Fettstoffwechselstörungen

  • Conference paper
Milde Hypertonie und leichte Fettstoffwechselstörungen

  • 19 Accesses

Zusammenfassung

Die Vermehrung der Blutfette stellt in den westlichen Industrienationen einen häufigen Befund dar. Bei etwa 15% der Erwachsenen besteht eine Hyperlipoproteinämie, wobei reine und vorwiegende Hypertriglyzeridämien gegenüber den Hypercholesterinämien wesentlich häufiger anzutreffen sind.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ahrens EH, Connor WE (1979) The evidence relating six dietary factors to the nation’s health. Report of a task force. Amer J Clin Nutr 32:2621–2748

    Google Scholar 

  2. Barndt R, Blankenhorn D, Crawford D, Brooks S (1986) Regression and progression of early femoral atherosclerosis in treated hyperlipoproteinemic patients. Ann Intern Med 86:139

    Google Scholar 

  3. Böttiger LE, Carlson LA (1980) Risk factors for ischaemic vascular death for men in the Stockholm prospective study. Atherosclerosis 36:389–408

    Article  Google Scholar 

  4. Brewer B (1981) Current concepts of the molecular structure and metabolism of human apolipoproteins and lipoproteins. Klin Wschr 59:1023

    Article  PubMed  CAS  Google Scholar 

  5. Castelli WP, Doyle JT, Gordon T, Harnes CG, Hjortland MC, Hulley SB, Kagan A, Zukel WJ (1977b) HDL cholesterol and other lipids in coronary heart disease: the cooperative lipo-protein phenotyping study. Circulation 55:767

    CAS  Google Scholar 

  6. Committee of Principal Investigators (1978) A cooperative trial in the primary prevention of ischaemic heart disease using clofibrate. Brit Heart J 40:1069

    Article  Google Scholar 

  7. Coronary Drug Project Research Group (1975) Clofibrate and niacin in coronary heart disease. J Amer med Ass 231:360–381

    Article  Google Scholar 

  8. Daoud A, Jarmolych J, Augustin J, Fritz K, Singh J, Lee K (1976) Regression of advanced atherosclerosis in swine. Arch Path 100:372

    CAS  Google Scholar 

  9. Dorr A, Gundersen K, Schneider J, Spencer T, Martin W (1978) Colestipol hydrochloride in hypercholesterolemic patients — effect on serum cholesterol and mortality. J chron Dis 31:5

    Article  PubMed  CAS  Google Scholar 

  10. Gotto AM, Miller NE, Oliver MF (1978) High density lipoproteins and atherosclerosis. El-sevier, Amsterdam

    Google Scholar 

  11. Kaffarnik H, Schneider J (1980) Klinik der Hyperlipoproteinämie. Ther Umsch 37:973–979

    PubMed  CAS  Google Scholar 

  12. Keys A (1980) Overweight, obesity, coronary heart disease and mortality. Nutr Rev 38:297–307

    Article  PubMed  CAS  Google Scholar 

  13. Keys A, Anderson JT, Grande S (1965) Serum cholesterol response to changes in the diet. Part. IV. Particular saturated fatty acids in the diet. Metabolism 14:776–784

    Article  CAS  Google Scholar 

  14. Klose G, Augustin J, Middelhoff G, Mordasini R, Greten H (1978) Grundlagen der medikamentösen Behandlung von Hyperlipidämien. Klin Wschr 56:99

    Article  PubMed  CAS  Google Scholar 

  15. Kuo P, Hayase K, Kostis J, Moreyra A (1979) Use of combined diet and colestipol in longterm treatment of patients with type II hyperlipoproteinemia. Circulation 59:199

    PubMed  CAS  Google Scholar 

  16. Levy R (1980) Hyperlipoproteinemia and its management. J Cardiovasc Med 5:435

    Google Scholar 

  17. LRC-CPPT-Trial-Results (1984) Reduction in incidence of coronary heart disease. JAMA 251:351

    Article  Google Scholar 

  18. LRC-CPPT-Trial-Results (1984) The relationship of reduction in incidence of coronary heart disease to Cholesterol lowering. JAMA 251:365

    Article  Google Scholar 

  19. Miettinen M, Turpeinen O, Karvonen M (1972) Effect of cholesterol-lowering diet on mortality from coronary heart disease and other causes. A twelve-year clinical trial in men and women. Lancet 11:835

    Article  Google Scholar 

  20. Miller G, Miller N (1975) Plasma-high-density-lipoprotein concentration and development of ischaemic heart disease. Lancet I:16

    Article  Google Scholar 

  21. Mordasini R, Oster P, Riesen W (1981) Medikamentöse Behandlung der Hyperlipidämien. Akt Endokr Stoffw 2:16

    Google Scholar 

  22. Oliver MJ, Heady JA, Morris N, Cooper J (1980) WHO cooperative trial on primary prevention of ischemie heart disease using clofibrate to lower serum cholesterol: mortality follow-up. Lancet II:379–385

    Google Scholar 

  23. Riesen W, Mordasini R, Oster P (1981) Ergebnisse der chemischen und immunologischen Bestimmung der Serumlipoproteine bei Hyperlipoproteinämien. Lab Med 5:103–111

    Google Scholar 

  24. Schettler G (1978) Die Ätiologie der Arteriosklerose. Internist (Berl.) 19:611

    CAS  Google Scholar 

  25. Schlierf G (1981) Primäre und sekundäre Prävention kardiovaskulärer Erkrankungen-metabolische Aspekte. Internist (Berl.) 22:68–71

    CAS  Google Scholar 

  26. Schlierf G, Geiss RD, Vogel G (1982) Ernährung bei Fettstoffwechselstörungen. 2. Aufl. Thieme, Stuttgart

    Google Scholar 

  27. Schlierf G, Oster P, Mordasini R (1982) Diagnostik und Therapie der Fettstoffwechselstörungen. Thieme, Stuttgart

    Google Scholar 

  28. Select Commitee on Nutrition and Human Needs (1977) U.S. Senate Dietary Goals for the United States, 2nd ed. U.S. Government Printing Office, Washington

    Google Scholar 

  29. Shekelle RB, Mac Millan Shryock A, Paul O, Lepper M, Stamler J, Liv S, Raynor WJ (1980a) Diet, serum cholesterol and death from coronary heart disease. The Western Electric Study. New Engl J Med 302:1219

    Article  Google Scholar 

  30. Slack J (1969) Risks of ischaemic heart disease in familial hyperlipoproteinemic states. Lancet II:1380

    Article  Google Scholar 

  31. Stamler JF, Epstein H (1972) Coronary heart disease — risk factors as guides to preventive action. Prevent Med 1:27

    Article  CAS  Google Scholar 

  32. Stary H (1979) Regression of atherosclerosis in primates. Virchows Archiv Abt A, 383:117

    CAS  Google Scholar 

  33. Wissler RW, Vesselinovitch D (1976) Studies of regression of advanced atherosclerosis in experimental animals and man. Ann NY Acad Sci 275:363–378

    Article  PubMed  CAS  Google Scholar 

  34. Wolfram G (1981a) Ernährungstherapie der Hyperlipidämien. Akt Endokr Stoffw 2:8–15

    CAS  Google Scholar 

  35. Wolfram G (1981b) Hyperlipidämien — Diätprinzipien und Kriterien ihrer Effizienz. Akt Ernähr 6:208–213

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tiefenauspital der Stadt und der Region Bern, CH-3004, Bern, Schweiz

    Priv.-Doz. Dr. R. Mordasini

Authors
  1. Priv.-Doz. Dr. R. Mordasini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. F. Riesen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abt. für Nieren- und Hochdruckkranke, Medizinische Klinik und Poliklinik der Universität Essen (GHS), Hufelandstraße 55, 4300, Essen 1, Germany

    M. Anlauf  & K. D. Bock  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt

About this paper

Cite this paper

Mordasini, R., Riesen, W.F. (1986). Krankheitsrisiko und Nutzen der Therapie bei Fettstoffwechselstörungen. In: Anlauf, M., Bock, K.D. (eds) Milde Hypertonie und leichte Fettstoffwechselstörungen. Steinkopff. https://doi.org/10.1007/978-3-642-72392-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72392-6_3

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-642-72393-3

  • Online ISBN: 978-3-642-72392-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation